Kevin Robert Lind is President and CEO of Longboard Pharmaceuticals, Inc.. Currently has a direct ownership of 0 shares of LBPH, which is worth approximately $0. The most recent transaction as insider was on Dec 02, 2024, when has been sold 363,740 shares (Common Stock) at a price of $60.0 per share, resulting in proceeds of $21,824,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
n/a 12M change
Total Value Held $0

Kevin Robert Lind Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 02 2024
SELL
Disposition due to a tender of shares in a change of control transaction
$21,824,400 $60.0 p/Share
363,740 Reduced 100.0%
0 Common Stock
Nov 13 2024
SELL
Bona fide gift
-
80,000 Reduced 18.03%
363,740 Common Stock
Nov 13 2024
BUY
Exercise of conversion of derivative security
$39,960 $3.12 p/Share
12,808 Added 2.81%
443,740 Common Stock
Aug 12 2024
BUY
Exercise of conversion of derivative security
$301,884 $3.66 p/Share
82,482 Added 16.07%
430,932 Common Stock
KRL

Kevin Robert Lind

President and CEO
La Jolla, CA

Track Institutional and Insider Activities on LBPH

Follow Longboard Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LBPH shares.

Notify only if

Insider Trading

Get notified when an Longboard Pharmaceuticals, Inc. insider buys or sells LBPH shares.

Notify only if

News

Receive news related to Longboard Pharmaceuticals, Inc.

Track Activities on LBPH